[AFFIN] QoQ TTM Result on 30-Sep-2014 [#3]

Stock
[AFFIN] AFFIN BANK BERHAD
Announcement Date
24-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- -6.61%
YoY- -14.38%
Quarter Report
Latest QR
Upcoming QR
AFFIN's Result
AFFIN's Financial Summary
View:
Show?
TTM Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 1,857,632 1,875,511 1,817,933 1,718,213 1,983,599 2,273,640 2,635,306 -20.84%
PBT 686,584 663,958 801,065 739,446 781,656 836,582 854,236 -13.58%
Tax -163,498 -173,370 -202,563 -183,893 -189,058 -194,667 -204,215 -13.81%
NP 523,086 490,588 598,502 555,553 592,598 641,915 650,021 -13.51%
-
NP to SH 512,035 480,034 592,677 550,982 589,997 641,915 650,021 -14.74%
-
Tax Rate 23.81% 26.11% 25.29% 24.87% 24.19% 23.27% 23.91% -
Total Cost 1,334,546 1,384,923 1,219,431 1,162,660 1,391,001 1,631,725 1,985,285 -23.31%
-
Net Worth 8,121,524 8,043,806 7,927,229 7,713,310 5,980,721 6,531,113 6,380,725 17.49%
Dividend
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Div 289,249 289,249 289,249 289,249 224,244 224,244 224,244 18.55%
Div Payout % 56.49% 60.26% 48.80% 52.50% 38.01% 34.93% 34.50% -
Equity
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Net Worth 8,121,524 8,043,806 7,927,229 7,713,310 5,980,721 6,531,113 6,380,725 17.49%
NOSH 1,942,948 1,942,948 1,942,948 1,942,948 1,495,180 1,494,534 1,494,315 19.18%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 28.16% 26.16% 32.92% 32.33% 29.87% 28.23% 24.67% -
ROE 6.30% 5.97% 7.48% 7.14% 9.86% 9.83% 10.19% -
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 95.61 96.53 93.57 89.10 132.67 152.13 176.36 -33.58%
EPS 26.35 24.71 30.50 28.57 39.46 42.95 43.50 -28.47%
DPS 15.00 14.89 14.89 15.00 15.00 15.00 15.00 0.00%
NAPS 4.18 4.14 4.08 4.00 4.00 4.37 4.27 -1.41%
Adjusted Per Share Value based on latest NOSH - 1,942,948
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
RPS 77.39 78.13 75.73 71.58 82.63 94.72 109.78 -20.84%
EPS 21.33 20.00 24.69 22.95 24.58 26.74 27.08 -14.74%
DPS 12.05 12.05 12.05 12.05 9.34 9.34 9.34 18.56%
NAPS 3.3833 3.3509 3.3023 3.2132 2.4915 2.7207 2.6581 17.50%
Price Multiplier on Financial Quarter End Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 -
Price 2.70 2.95 2.90 3.40 3.31 3.87 4.15 -
P/RPS 2.82 3.06 3.10 3.82 2.49 2.54 2.35 12.96%
P/EPS 10.25 11.94 9.51 11.90 8.39 9.01 9.54 4.91%
EY 9.76 8.38 10.52 8.40 11.92 11.10 10.48 -4.64%
DY 5.56 5.05 5.13 4.41 4.53 3.88 3.61 33.47%
P/NAPS 0.65 0.71 0.71 0.85 0.83 0.89 0.97 -23.47%
Price Multiplier on Announcement Date
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Date 17/08/15 20/05/15 26/02/15 24/11/14 15/08/14 19/05/14 26/02/14 -
Price 2.11 2.90 2.94 3.05 3.43 3.68 4.10 -
P/RPS 2.21 3.00 3.14 3.42 2.59 2.42 2.32 -3.19%
P/EPS 8.01 11.74 9.64 10.67 8.69 8.57 9.43 -10.33%
EY 12.49 8.52 10.38 9.37 11.50 11.67 10.61 11.52%
DY 7.11 5.13 5.06 4.92 4.37 4.08 3.66 55.87%
P/NAPS 0.50 0.70 0.72 0.76 0.86 0.84 0.96 -35.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment